Indoritel Makmur Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indoritel Makmur Internasional Tbk. trades at Rp9,800 (market cap 138.29T, 28.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Indoritel Makmur Internasional Tbk. is far larger — about 826.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 28.5K). Which is the better fit depends on your goals.
| DNET | OBAT | |
|---|---|---|
Market Cap | 138.29T | 167.37B |
Volume | 28.5K | 71K |
Lot | 285 | 710 |
Turnover | 279.88M | 17.51M |
Average Price | 9,820.44 | 246.63 |
Value | 279.88M | 17.51M |
Indicative Equilibrium Price | 9,800 | 246 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indoritel Makmur International Tbk, (formerly PT. Dyviacom Intrabumi, Tbk) was established based on Notarial Deed of Siti Pertiwi Henny Singgih, S.H., No 107 dated November 16, 1995, and has a vision to take part in changing the proper lifestyle to the cyber technology era. In early 1997, The Company launched DIFFY.COM to extends its business.
Read more on DNET →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →